The QualityStocks Daily Wednesday, April 10th, 2019

Today's Top 3 Investment Newsletters

TopPennyStockMovers (ATAI) +81.60%

OTCtipReporter (INPX) +47.87%

MarketClub Analysis (MARA) +42.44%

The QualityStocks Daily Stock List

Medicine Man Technologies, Inc. (MDCL)

Penny Stock Tweets, YCharts, New Cannabis Ventures, Investing Daily, Uptick Newswire, MarketWatch, The Street, Daily Marijuana Observer, Stockhouse, Technical420, Green Market Report, Morningstar, Barchart, Insider Financial, Simply Wall St, GuruFocus, PR Newswire, Marketbeat, and Cannabis Life Network reported earlier on Medicine Man Technologies, Inc. (MDCL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQX-listed, Medicine Man Technologies, Inc. is a vertically integrated cannabis operator. The Company provides consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors, and retailers. It is leveraging its significant expertise and intellectual property (IP) to vertically integrate into plant-touching cannabis operations. Medicine Man Technologies has its corporate office in Denver, Colorado.

The Company commenced 2019 with announcing the pending revenue positive acquisitions of Medicine Man Denver and MedPharm. Futurevision Ltd. (dba Medicine Man Denver) is a profitable operator with an anticipated $25M run rate for this year. It opened its first store in 2009 and currently has 4 locations. It is a well-known industry leader in the cannabis business in the State of Colorado and has a large cultivation facility.

MedPharm is a fast-growing revenue positive pharmaceutical-grade cannabis operator expecting profitability this year. It cultivates, processes and formulates to pharmaceutical standards for medical and recreational users.

In essence, Medicine Man Technologies is taking advantage of its know-how and IP to vertically integrate retail, cultivation, formulation and distribution operations. Its client portfolio includes active and past clients in 18 states and seven countries.

Recently, Medicine Man opened its newest retail dispensary in Longmont, Colorado, on February 20, 2019. The store opening comes after the Company's January announcement of entering a binding agreement anticipated to lead to the near-term acquisition of Medicine Man by Medicine Man Technologies (MDCL). The new dispensary is strategically located on "Car Row" with auto dealerships close by, guaranteeing higher than normal foot traffic for retail sales.

Yesterday, Medicine Man Technologies announced that it will be presenting at the 3rd Annual Benzinga Cannabis Capital Conference, to be held April 17-18, 2019 at the Fairmont Royal York in Toronto, Ontario. Mr. Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies, will deliver a corporate presentation and discuss recent highlights of the Company on Thursday, April 18 at 11:20 a.m. ET in the British Columbia Room.

Medicine Man Technologies, Inc. (MDCL), closed Wednesday's trading session at $2.62, up 8.26%, on 287,777 volume with 516 trades. The average volume for the last 3 months is 123,116 and the stock's 52-week low/high is $1.06/$2.53.

chart

Frélii, Inc. (FRLI)

DNA Investor Alerts, Trade Ideas, Current Charts, Market Screener, Business Wire, Wallet Investor, Investing Online, Seeking Alpha, MarketWatch, Simply Wall St, Last10k, Investors Hangout, Northfield Review, and The Health Investor reported earlier on Frélii, Inc. (FRLI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Frélii, Inc. is a medical technology company headquartered in Lehi, Utah. It uses gene sequencing and artificial intelligence (AI) to determine risk and lifestyle modifications. Its technology analyzes the most comprehensive markers (60,000,000-plus) on the market to date. The Company was previously known as Vican Resources, Inc. It changed its name to Frélii, Inc. in March of 2018. Frélii's shares trade on the OTCQB.

The Company's technology generates accurate and significantly valuable insight into DNA. The Company says that it opens opportunities never realized in health care, precision medicine, insurance, corporate wellness and personal health and risk identification.

Fundamentally, Frélii is data mining DNA. It takes advantage of the big data of DNA to improve health and wellness and enhance the human experience. The design of the Company's technology has been to allow assessment and sequencing, for reporting needs into different life science environments.

Frélii takes an inventive approach to health through leveraging its highly advanced AI to deliver more holistic DNA analysis. This is to provide precision concerning what medical professionals and individuals need regarding correct drugs, dosing, diet and interventions.

The Company continues to develop and grow its patented AI technology, leveraged base code and large data sets gathered from public and private partnerships. Its predictive capacity with its precision medicine and health and wellness AI has increased from 84 percent to 98.5 percent. Furthermore, the flagship high-efficiency Genetic Sequencing and analysis using Frélii's proprietary technology has increased to over 99 percent and 99.999 percent accuracy on whole genome and exome sequencing, respectively.

Last month, Frélii announced that it signed a Memorandum of Understanding (MOU) with NewPath Health Care Solutions, Inc. of Ontario, Canada; Mercator Biologic, Inc. of Centerville, Utah; and True DNA Story, LLC of Centerville, Utah. The purpose of the MOU is to strategically explore the complete capabilities of each company to identify synergies and opportunities in order to take advantage of the unique skillsets of the collective.

Mr. Ian Jenkins, Chief Executive Officer of Frélii, said, "The four companies that are a part of the agreement have each developed technologies, methodologies, processes and solutions that are unique and powerful and lend themselves to game-changing collaborations and innovations. Frelii will offer its highly advanced artificial-intelligence-based technology platform to the group, and also benefit from their technology and expertise to further our corporate growth and market objectives.

Frélii, Inc. (FRLI), closed Wednesday's trading session at $2.0525, up 2.62%, on 5,198 volume with 13 trades. The average volume for the last 3 months is 34,152 and the stock's 52-week low/high is $1.05/$3.00.

chart

Cobalt 27 Capital Corp. (CBLLF)

Hottest Stock Picks, Energy and Capital, Streetwise Reports, Barchart, MarketWatch, Proactive Investors, Morningstar, Tip Ranks, Dividend Investor, Market Screener, InvestorsHub, Seeking Alpha, Junior Mining Network, Metals News, GuruFocus, The Street, and Wallet Investor reported on Cobalt 27 Capital Corp. (CBLLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Cobalt 27 Capital Corp. is a foremost battery metals streaming company listed on the OTC Markets' OTCQX. The Company offers exposure to metals essential to key technologies of the electric vehicle and energy storage markets. Cobalt 27 Capital's intention is to continue investing in an electric metals-focused portfolio of streams, royalties and direct interests in mineral properties containing cobalt. This is while potentially adding to its cobalt physical holdings when opportunities arise. Cobalt 27 Capital has its corporate headquarters in Toronto, Ontario.

The Company's strategy of holding physical cobalt, streams and royalties will avoid the operational, environmental, closure and capital risks associated with typical mining companies. Likewise, Cobalt 27 Capital will not be exposed to any operational risks carried by automakers and battery producers. Through holding physical cobalt and electric metals focused streams and royalties, it will be able to participate in price appreciation while minimizing exposure to risks.

Cobalt 27 owns physical cobalt and a 32.6 percent Cobalt Stream on Vale's world-class Voisey's Bay mine,‎ beginning in 2021. The Company is undertaking a friendly acquisition of Highlands Pacific that is expected to add increased attributable nickel and cobalt production from the long-life, world-class Ramu Mine.

In addition, Cobalt 27 manages a portfolio of 11 royalties. The Company's acquisition strategy is to fully exploit present market opportunities to invest in streams and royalties and deliver growth as the leading electric metals investment vehicle.

Last month, Cobalt 27 Capital provided a status update on its earlier announced acquisition of Highlands Pacific Limited, through a definitive scheme implementation agreement, whereby Cobalt 27 proposes to acquire all of the issued ordinary shares of Highlands that it does not own by means of a scheme of arrangement under Part XVI of the PNG Companies Act in Papua New Guinea (PNG).

Highlands is a mining and exploration company and its main assets include an 8.56 percent interest in the producing Ramu mine and a 20 percent interest in the Frieda River Copper-Gold Project, both in PNG. Additionally, Highlands holds the Star Mountains Copper Gold exploration project in PNG and has exploration tenements on Normanby Island (Sewa Bay).

On March 12, 2019, Highlands filed the Independent Expert's Report concluding the Scheme is fair and reasonable, and consequently in the best interests of Highlands' shareholders. The National Court of PNG ordered a meeting for Highlands' shareholders to vote on the Scheme that has been set for April 30, 2019.

Cobalt 27 is now Highlands' single largest shareholder, having increased its equity interest from 13 percent to roughly 19.99 percent during Q1 of 2019. Highlands' 45-day period to approach other parties for better offers on its project interests ended February 16, 2019. Upon close of the proposed Highlands acquisition, Cobalt 27 will gain an 8.56 percent interest in the producing Ramu nickel-cobalt mine.

Cobalt 27 Capital Corp. (CBLLF), closed Wednesday's trading session at $3.16, up 3.23%, on 1,900 volume with 10 trades. The average volume for the last 3 months is 20,291 and the stock's 52-week low/high is $2.45/$10.00.

chart

Enthusiast Gaming Holdings, Inc. (EGHIF)

Street Signals, Stockwatch, The Street, OTC Markets, Wallet Investor, MicroSmallCap, GlobeNewswire, Stockhouse, InvestorsHub, Seeking Alpha, Market Screener, GuruFocus, and Trading View reported earlier on Enthusiast Gaming Holdings, Inc. (EGHIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Formed in 2014, Enthusiast Gaming Holdings, Inc. is the fastest-growing online community of video gamers. The Company has a platform of more than 80 owned and affiliated websites. It currently reaches greater than 75 million monthly visitors with its innovative and curated content and over 50 million YouTube visitors. Enthusiast Gaming Holdings lists on the OTC Markets Group's OTCQB. The Company is headquartered in Toronto, Ontario.

Enthusiast Gaming concentrates on building the largest network of authentic gaming enthusiasts, via events, original content, as well as advertising. The Company also owns and operates Canada's largest gaming expo, Enthusiast Gaming Live Expo, EGLX, (eglx.ca) with more than 55,000 people attending last year.

Enthusiast Gaming's innovative growth strategy adds to the website monetization potential, which powers its platforms and partners. At present, the Company is generating more than one billion ad requests per week via Enthusiast Gaming Media and affiliated partners.

Last week, Enthusiast Gaming announced that its esports community, Daily Esports (dailyesports.gg), reported record-breaking quarterly visitor growth since the acquisition in March of last year. The digital property saw a 4X pageview increase within the quarter. This represents an increase of 135 percent in visitor traffic over the prior quarter. It has added 288,000 unique monthly visitors to its overall readership since the acquisition.

Since the acquisition, Enthusiast Gaming and its Director of Content, Niero Gonzalez and Director of Special Projects, Jason Lepine have built out the Daily Esports team. This includes new Editor-in-Chief, Taha Zaidi, and 28 freelance writers. Daily Esports is one of the top online communities of esports content around breaking news, game patches, analysis, opinion, tournament coverage, and more.

Yesterday, Enthusiast Gaming announced that it has, via a wholly-owned subsidiary, signed a definitive agreement to purchase 20 percent of the issued and outstanding shares in Waveform Entertainment, Inc. for total consideration of $1,680,000. Waveform Entertainment is a foremost esports broadcast and production company. It specializes in the organization of premium esports tournaments internationally. Furthermore, Enthusiast Gaming secured an irrevocable option, at its sole discretion, to acquire a 100 percent interest in Waveform.

Enthusiast Gaming Holdings, Inc. (EGHIF), closed Wednesday's trading session at $1.0686, up 5.80%, on 17,880 volume with 19 trades. The average volume for the last 3 months is 10,207 and the stock's 52-week low/high is $0.611/$0.118.

chart

Ionix Technology, Inc. (IINX)

Small Cap Exclusive, Market Exclusive, Wallmine, OTC Markets, Simply Wall St, Stockhouse, Financial Content, Wallet Investor, YCharts, Barchart, The Street, Morningstar, MarketWatch, Stockopedia, Last10k, Dividend Investor, Open Insider, and Current Charts reported previously on Ionix Technology, Inc. (IINX), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Ionix Technology, Inc. is a business aggregator in photoelectric display and smart energy fields. It is concentrating on becoming the business aggregator that primarily promotes photoelectric display, smart energy and lead industrial technology development since restructuring.  Through incorporating high quality enterprises and innovating forward-looking technologies, Ionix provides more optimized green energy solutions. The Company previously went by the name Cambridge Projects, Inc. It changed its name to Ionix Technology, Inc. in February of 2016.

Ionix Technology has four operating subsidiaries. One is Changchun Fangguan Photoelectric Display Technology Co., Ltd, which specializes in developing, designing, producing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules and other related products. Another subsidiary is Shenzhen Baileqi Electronic Technology Co., Ltd, which specializes in LCD slicing, filling, researching and designing, manufacturing and selling of LCD Modules (LCM) and PCBs.

Subsidiary Lisite Science Technology (Shenzhen) Co., Ltd., engages in the production of intelligent electronic devices. Furthermore, subsidiary Dalian Shizhe New Energy Technology Co., Ltd., engages in photo-voltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three-dimensional parking. At present, the Company has embarked on the layout of industrialization and marketization of front end materials and back end modules of flexible folding liquid crystal displays by taking Changchun Fangguan and Shenzhen Baileqi as production bases, to capture the market share of OLED high technology.

This past January, Ionix Technology announced that it entered into certain VIE Transaction Documents with certain shareholders of Changchun Fangguan Electronics Technology Co., Ltd. Changchun Fangguan is a top manufacturer in the liquid crystal displays field. Through entering into specific VIE Transaction Documents, Ionix acquired control of Changchun Fangguan.

Yubao Liu, Chief Executive Officer of Ionix Technology, said, "This acquisition of control of Changchun Fangguan is a great milestone for our company's development, and a crucial part of corporate restructuring strategy. As a pioneer in the field of LCDs in China, Changchun Fangguan is one of the few domestic LCD manufacturers that is capable of meeting the industry needs as well as providing LCD, LCM and TFT-LCM products in batches."

Last week, Ionix Technology announced that its subsidiary Changchun Fangguan Electronics Technology Co., Ltd. completed a capital increase of USD 5.92 Million to invest in its OLED flexible screen business. In December of 2018, Ionix Technology acquired 95.14 percent control of Changchun Fangguan. Thus, Ionix became an aggregator in the photoelectric display and smart energy fields in China, which has also laid a strong basis for its prospective future development and technology innovation.

Ionix Technology, Inc. (IINX), closed Wednesday's trading session at $2.12, down 12.03%, on 9,700 volume with 16 trades. The average volume for the last 3 months is 2,069 and the stock's 52-week low/high is $1.20/$2.75.

chart

Pulse Evolution Group, Inc. (DGLF)

TMX Money, Stockhouse, Street Insider, Morningstar, Seeking Alpha, InvestorsHub, Simply Wall St, Barchart, GlobeNewswire, Guru Focus, OTC Markets, and Investors Hangout reported on Pulse Evolution Group, Inc. (DGLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Pulse Evolution Group, Inc. is a foremost developer of hyper-realistic digital humans and characters for entertainment, mixed reality and artificial intelligence (AI). In August 2018, the Company acquired Evolution AI Corporation, a developer of digital humans as an 'inter-Face' of AI applications. This included its majority interest in Pulse Evolution Corporation (PLFX).

Pulse Evolution Group lists on the OTC Markets OTCQB and the Company has its head office in New York, New York. It previously went by the name Recall Studios, Inc. It changed its corporate name to Pulse Evolution Group, Inc. in February of this year.

Pulse engages in the development of human animation technology to enable AI platforms to interact with consumers in the relatable form of human faces and human characters. The Company also engages in the development of hyper-realistic digital humans and computer-generated assets that perform in live shows, virtual reality, augmented reality, holographic, 3D stereoscopic, Web, mobile, interactive, and AI applications. It also engages in the storage, protection, and distribution of virtual facebanks.

Pulse Evolution Group centers on creating software and experiential applications that elevate the way consumers interact with content. The Company's main strategy has been focused on the growing market of Mixed Reality (virtual reality and augmented reality) with a portfolio of proprietary technology (including two patents pending), which is ready for market and scheduled for commercial introduction.

This week, Pulse Evolution Group announced it has been added to the roster of leading partners for Broadway Asia's theatrical production of DreamWorks' Kung Fu Panda Spectacular Live at the Venetian Theatre in Macau. Mr. John Textor, Pulse Evolution Group's Chief Executive Officer, said, "We are delighted to have been asked to join this incredible group of people and companies in such a highly anticipated DreamWorks' production.

Producers Simone Genatt and Marc Routh are among the most experienced and successful theatrical producers in Asia and they have assembled a first-class team, along with director Susan Stroman, to bring Asia's most successful animation franchise to life in a way that will leave audiences with memories for a lifetime."

Pulse Evolution Group, Inc. (DGLF), closed Wednesday's trading session at $7.50, down 6.25%, on 618 volume with 13 trades. The average volume for the last 3 months is 860 and the stock's 52-week low/high is $3.29/$23.625.

chart

Westleaf, Inc. (WSLFF)

Stock Target Advisor, Barchart, Investor Ideas, Insider Financial, Pinnacle Digest, Wallmine, Trading View, Stockwatch, MarketWatch, Stockhouse, YCharts, Midas Letter, InvestorsHub, Technical420, Business Insider, Morningstar, and Investors Hangout reported previously on Westleaf, Inc. (WSLFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Westleaf, Inc. engages in the cultivation, extraction, distribution, and sale of cannabis and cannabis related products. The Company is a vertically integrated cannabis business. It has assets owned and under development across cultivation, extraction, processing, manufacturing, and wholly-owned retail. Westleaf has its corporate headquarters in Calgary, Alberta.

The Company is developing a national presence of retail stores called Prairie Records. This is a brand that celebrates the instinctual tie between music and recreational cannabis. Prairie Records provides access to the country's best cannabis. It is a reinvention of the cannabis purchasing experience in a high design, sophisticated retail space, reflecting that of a contemporary record store.

Westleaf's brands also include Loon Cannabis and Westleaf Cannabis. Loon Cannabis is a health and wellness cannabis line. The design of it is to help customers live their optimal lives, so they can thrive and enjoy life with clarity and peace of mind. Loon Cannabis has an array of calming strains and unique products. Westleaf Cannabis created a signature brand of medicinal cannabis products for customers looking to treat symptoms of illness and other conditions. The design of the products is to help customers lessen pain or to moderate side effects from ongoing health conditions.

Last month, Westleaf announced it has been included on the Horizons Marijuana Life Sciences ETF (HMMJ) (TSX: HMMJ). HMMJ is an index (or passively managed) ETF. It seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The design of the index is to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the cannabis industry.

Last week, Westleaf announced it launched its e-commerce site for sales across the entire Province of Saskatchewan. The retail site, at www.prairierecords.ca, provides consumers in Saskatchewan convenient online access to a broad assortment of products via the inventive Prairie Records retail concept that combines music and cannabis in an engaging online experience.

Prairie Records concentrates exclusively on densely populated neighborhoods, high traffic areas, and tourist destinations. The basis of the retail concept is ingrained with a desire to create an innovative cannabis buying experience through tactile in-store features and product offerings celebrating the relationship between music and cannabis.

Westleaf, Inc. (WSLFF), closed Wednesday's trading session at $1.60, up 1.91%, on 74,386 volume with 151 trades. The stock's 52-week low/high is $1.327/$5.00.

chart

Novo Integrated Sciences, Inc. (NVOS)

Tip Ranks, Morningstar, YCharts, Trading View, Last10k, Barchart, Simply Wall St, Wallet Investor, Stockhouse, MarketWatch, Equity Clock, The Street, and GuruFocus reported earlier on Novo Integrated Sciences, Inc. (NVOS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc., via Novo Healthnet Limited, delivers multi-disciplinary primary healthcare to greater than 400,000 patients annually. The Company does so by way of its 15 corporate-owned clinics and a contracted network of 97 affiliate clinics and 222 eldercare centric homes located throughout Canada. Novo Integrated Sciences is headquartered in Bellevue, Washington and the Company lists on the OTCQB.

Novo continues to build its health science platform of services and products via the integration of technology and rehabilitative science. One element of the Company's lateral business growth strategy includes developing business units focused on the direct control of the grow, extraction, manufacturing and distribution processes for hemp and medical cannabidiol products.

Novo Integrated Sciences continues to expand on its patient care philosophy of maintaining a continuing connection with its patient community through extending oversight of patient diagnosis, care and monitoring, directly into the patient's home, by way of different mobile telemedicine and diagnostic tools.

Novo's specialized services and products include physiotherapy, chiropractic care, chiropody, occupational therapy, eldercare, laser therapeutics, and massage therapy. Services and products additionally include acupuncture, neurological functions, kinesiology, concussion management and baseline testing, women's pelvic health, sports medicine therapy, assistive devices and private personal training. The Company does not provide primary care medical services. Moreover, none of its employees practices primary care medicine. In addition, its services do not necessitate a medical or nursing license.

Recently, Novo Integrated Sciences, Inc. and Novo Healthnet Limited (NHL), a wholly-owned subsidiary of Novo Integrated Sciences, announced the signing of a definitive Share Purchase and Exchange Agreement (SPEA), dated February 20, 2019, with Pulse Rx, Inc. and with the shareholders of Pulse Rx. Pulse Rx is a private Canadian limited company operating as Pulse Rx LTC Pharmacy. Pulse Rx provides pharmacy services to long-term care and retirement residences in the Province of Ontario.

Mr. Robert Mattacchione, Novo Integrated Sciences' Chief Executive Officer and Board Chairman, stated, "The addition of Pulse Rx to our Canadian healthcare holdings represents the continued manifestation of our lateral growth objectives. The synergy of this acquisition will be felt across several existing NHL business silos with the most immediate impact being to our eldercare division and its ability to offer a more comprehensive array of core products and services across an expanding geriatric demographic."

Last month, Novo Integrated Sciences and Novo Healthnet Limited (NHL) announced the signing of an exclusive Licensing Agreement with Cloud DX, Inc. Cloud DX is an award-winning medical device company, operating in the U.S. and Canada. It develops hardware and related software for Remote Patient Monitoring and Chronic Care Management.

This Licensing Agreement provides NHL with perpetual licensing rights to the Bundled Pulsewave PAD-1A USB Blood Pressure Device, related software and up-to-date product releases. Moreover, the License Agreement provides NHL with conditional exclusive rights, over the initial 5-year period, to sub-license and re-sell Bundled Pulsewave Devices and related software.

Novo Integrated Sciences, Inc. (NVOS), closed Wednesday's trading session at $1.50, up 0.67%, on 865 volume with 4 trades. The average volume for the last 3 months is 2,753 and the stock's 52-week low/high is $0.302/$2.99.

chart

SOL Global Investments Corp. (SOLCF)

Midas Letter, Whale Wisdom, CannabisMarketCap, Financial Buzz, InvestorIntel, MarketWatch, InvestorsHub, YCharts, Marijuana Stock Review, Marketbeat, Investor Ideas, Barchart, Pot Stock News, Market Screener, Business Wire, Investorx, and Stockwatch reported earlier on SOL Global Investments Corp. (SOLCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

SOL Global Investments Corp. is a global investment company listed on the OTC Markets' OTCQB. The Company centers on, but is not limited to, cannabis and cannabis related companies in legal U.S. States, the hemp and CBD (cannabidiol) marketplaces, and the developing European cannabis and hemp marketplaces. SOL Global Investments has its corporate headquarters in Toronto, Ontario. It also has offices in Fort Lauderdale, Florida, and London, England.

The Company has strategic investments and partnerships across cultivation, distribution and retail. These complement its research and development (R&D) program with the University of Miami. SOL Global is positioning the Company as a future frontrunner in the United States' medical cannabis industry.

SOL's investments include ECH Ltd.; Verano Holdings LLC; OG DNA Genetics, Inc.; Greenlight Pharmaceuticals Limited; University of Miami; and PRØHBTD Media, Inc. ECH is a group of companies at the vanguard of the European medical cannabis industry. Verano Holdings is a private, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. States and Puerto Rico.

OG DNA Genetics is one of the foremost companies in the Cannabis Industry. Greenlight Pharmaceuticals Limited (GreenLight Medicines) is a biopharmaceutical company focused on researching, developing and licensing molecules from proprietary cannabinoid formulations to target a spectrum of disease areas.

Last week, SOL Global Investments announced its intention to spin off its wholly-owned subsidiary, Scythian Biosciences, Inc. (SBI), into an independent, publicly-traded company. Upon closing of the Spin-off, expected to take place on or before September 30, 2019, SOL Global Investments' shareholders will own shares of both companies. With this Spin-off, SBI will be renamed "Impact Biosciences Corp." It will continue to pursue a drug development in the U.S. for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate that is undergoing development under contract with the University of Miami.

Today, SOL Global Investments announced the completion of its acquisition of CannCure Investments, Inc. CannCure is a privately-held Ontario corporation that indirectly holds 100 percent of 3 Boys Farms, LLC, a Florida limited liability company with a Florida state license to cultivate, process and dispense medical marijuana.

3 Boys Farms' operations comprise 40,000 square feet of fully-operational greenhouses situated on an eight-acre parcel of land. The existing facilities include a two-acre outdoor mitigation space, which is run 100 percent with harvested rainwater, solar pumps and repurposed high-volume chilled air from the cultivation greenhouses. This results in a zero-carbon footprint. 3 Boys Farms' innovations include alternative energy use, greenhouse cooling designs, and rainwater harvesting. Its innovations were recognized and honored by the Governor's Environmental Leadership Award. Also, 3 Boys Farms has started extraction and processing operations at its new GMP-certified farm and laboratory facility in Indiantown, Florida.

SOL Global Investments Corp. (SOLCF), closed Wednesday's trading session at $2.30, up 2.68%, on 63,170 volume with 71 trades. The average volume for the last 3 months is 77,259 and the stock's 52-week low/high is $0.768/$13.55.

chart

Valens GroWorks Corp. (VGWCF)

Market Screener, New Cannabis Ventures, Canadian Insider, Barchart, The Street, GuruFocus, Stockwatch, Cannabis Market Cap, Technical420, MarketWatch, Dividend Investor, Pot Stock News, Investor Ideas, InvestorsHub, Investing News, Trading View, Midas Letter, Equities, Proactive Investors, and Stockhouse reported previously on Valens GroWorks Corp. (VGWCF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Valens GroWorks Corp. is a multi-licensed provider of cannabis products and services. The Company focuses on different proprietary extraction methodologies, distillation, cannabinoid isolation and purification, and associated quality testing. Established in 2012, Valens is a research-driven Canadian cannabis company that has three wholly-owned subsidiaries located in and around Kelowna, British Columbia.

Valens GroWorks is one of the largest businesses in the supply chain. The Company is a world-class, premium cannabis processor and testing facility with the standards and compliance to operate at an international scale. Its corporate mission is to become the world's most trusted partner for best-in-class cannabis extraction, testing, formulations and product development.

Valens has 240,000kg of capacity and growing and is equipped to service Canadian demand as well as worldwide markets with efficiency at scale. The Company's formulation and testing expertise allows for the production of a broad assortment of tinctures, capsules, concentrates, vapes, topicals, beverages and edibles. Valens provides customers with the broadest array of extraction techniques that allows them to produce the largest range of end products.

Subsidiary Valens Agritech (VAL) holds a license to cultivate cannabis and produce cannabis oil under the Cannabis Act. VAL also has a license to conduct analytical testing for the cannabis industry. At present, it has extraction processing and supply agreements with diverse top producers throughout Canada.

In addition, subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab. Valens Labs provides sector-leading analytical services. It has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science.

Furthermore, subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards. This will ensure that the product from this facility can be exported anywhere globally where cannabis is nationally legal for medical or adult usage purposes.

Last month, Valens GroWorks announced that it entered into a multi-year extraction services agreement to provide cannabis and hemp extraction services to The Green Organic Dutchman Holdings Ltd. (TGOD). TGOD is a premium worldwide organic cannabis business. Its operations are centered on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, and also the Canadian adult-use market.

With this initial 2-year agreement, TGOD will supply Valens GroWorks with an annual minimum of 30,000kg in the first year, increasing to 50,000kg in year two, of cannabis and hemp biomass that Valens will process into premium quality resins and distillates employing certified organic extraction processing methods.

Mr. Tyler Robson, Chief Executive Officer of Valens GroWorks, said, "We are excited to work with TGOD, Canada's premier certified organic producer. Organic resonates with consumers, and Valens looks forward to helping accelerate TGOD's time to market with the launch of its hemp-derived CBD product line in the coming months."

Valens GroWorks Corp. (VGWCF), closed Wednesday's trading session at $2.7633, up 13.25%, on 254,417 volume with 317 trades. The average volume for the last 3 months is 140,043 and the stock's 52-week low/high is $0.794/$2.67.

chart

iAnthus Capital Holdings, Inc. (ITHUF)

InvestorsHub, Stockhouse, MarketWatch, New Cannabis Ventures, GuruFocus, Daily Marijuana Observer, Morningstar, Barchart, OTC Markets, and Proactive Investors reported earlier on iAnthus Capital Holdings, Inc. (ITHUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

iAnthus Capital Holdings, Inc. is a provider of capital investment and management services to licensed cannabis cultivators, processors, and dispensaries across the U.S. The Company, by way of its 100 percent owned subsidiary, iAnthus Capital Management, LLC, delivers a complete solution for financing and managing these enterprises. iAnthus supports a diverse portfolio of cannabis industry investments. OTCQX-listed, iAnthus Capital Holdings is headquartered in New York, New York.

iAnthus provides a unique combination of capital and practical operating and management expertise. The Company creates agreements that establish valuable partnerships. It has developed strategic partnerships with best-in-class industry-sector leaders in dispensary operations, commercial-scale cannabis cultivation, regulatory law, and the science of cannabis product formulation and testing. Moreover, iAnthus continues to market its award-winning line of MPX-branded products.

At present, iAnthus has operations in 11 states, and operates 20 dispensaries. The Company is rapidly progressing its long-term plan to install more than half-a-million square feet of cultivation at its Lake Wales, Florida, campus. iAnthus' New York State operation is one of only ten licensed medical cannabis Registered Organizations in the State. In addition, the Company's Brooklyn location opened in late 2018. It is one of only three stores serving a city of 2.6 million.

iAnthus Capital Holdings has opened two dispensaries in Florida. This includes its flagship store in West Palm Beach. iAnthus has plans to quickly expand through 2019. It will be adding roughly one store a month. At the same time, it will be expanding its cultivation and processing operations.

In the State of Massachusetts, iAnthus is building a 41,000-square-foot facility. It will accommodate a fully integrated license, which includes cultivation, production and a dispensary on 12 acres in the Fall River area. This is in addition to the Company's 30,000-square-foot facility in Holliston. Furthermore, in Vermont, iAnthus has made major upgrades to its 6,000-square-foot cultivation and processing facility in Brandon. The Company has also started construction on a 49,700-square-foot medical cannabis cultivation and processing facility in Warwick, New York.

Last week, iAnthus Capital Holdings announced that it opened its second New York dispensary in the Dutchess County town of Wappingers Falls. This dispensary will operate as "Citiva Hudson Valley" under the iAnthus' "Citiva" New York dispensary brand. This retail location will initially offer greater than 30 locally-sourced, lab-tested products, including vape cartridges, tinctures, capsules, and powders, dispensed by highly-knowledgeable patient care representatives.

iAnthus Capital Holdings, Inc. (ITHUF), closed Wednesday's trading session at $5.05, up 0.40%, on 561,746 volume with 1,131 trades. The average volume for the last 3 months is 487,125 and the stock's 52-week low/high is $2.29/$7.27.

chart

BioHiTech Global, Inc. (BHTG)

Stock Twits, OTC Markets, Market Exclusive, Dividend Investor, Real Investment Advice, Stockopedia, Barchart, Market Screener, Zacks, last10k, Insider Financial, Stockaholics, YCharts, Talk Traders, Stockhouse, MarketWatch, Wallet Investor, Market News Updates, InvestorsHub, Street Insider, 4-Traders, and Trading View reported earlier on BioHiTech Global, Inc. (BHTG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

BioHiTech Global, Inc. is a green technology business that provides unique data-driven solutions for food waste disposal. The Company develops and deploys innovative and disruptive waste management technologies. BioHiTech Global is a leader in zero waste solutions for businesses and municipalities of all sizes. NasdaqCM-listed, BioHiTech Global has its corporate headquarters in Chestnut Ridge, New York.

In 2016, BioHiTech Global expanded its waste stream product offering with the launch of Entsorga North America. The Entsorga North America undertaking expands the Company's product offering towards providing disruptive, clean technology solutions that advance the worldwide movement towards sustainability and zero waste initiatives.

  BioHiTech Global provides waste management solutions to an international customer base covering a complete set of technology-based disposal options, which can have a significant effect on waste generation. This is while providing a true zero landfill environment.

BioHiTech Global has launched its BioHiTech Alto™. This is a next generation interactive industrial communication technology. BioHiTech Alto™ enables users to communicate intelligently with industrial equipment in real-time. BioHiTech Alto is a vital new element of the Company's total food waste solution that uses data and analytics to help drive smarter business decisions. Furthermore, BioHiTech Global launched BioHiTech Cirrus. This is a mobile application for complete insight into the waste stream.

BioHiTech Global announced this past December that its Entsorga West Virginia, LLC (EWV) subsidiary completed an $8 million tax-exempt bond financing to finalize construction and commence operations at the nation's first HEBioT™ renewable resource recovery facility in Martinsburg, West Virginia. BioHiTech Global earlier entered into a definitive agreement to become the largest owner of EWV.

BioHiTech Global's plan is to build a series of facilities using the patented HEBioT process in the U.S. in the coming years. A second site is presently under development in Rensselaer, New York, with other potential locations in early stage planning.

In December 2018, BioHiTech Global announced that a portfolio company of Kinderhook Industries, a private investment firm that manages more than $2.0 billion of committed capital, contributed $3.5 million in cash and assets valued at roughly $2 million in exchange for a 40 percent stake in a newly created BioHiTech consolidated subsidiary. The New Subsidiary currently owns a 78 percent equity interest in the nation's first HEBioT™ facility in Martinsburg, West Virginia and certain assets related to BioHiTech's Rensselear HEBioT development project. This New Subsidiary will serve as the stage for BioHiTech's planned HEBioT facility rollout in the U.S.

BioHiTech Global, Inc. (BHTG), closed Wednesday's trading session at $2.79, up 1.09%, on 16,160 volume with 89 trades. The average volume for the last 3 months is 25,703 and the stock's 52-week low/high is $1.60/$5.76.

chart

PharmaCyte Biotech, Inc. (PMCB)

SmallCapNetwork, MyBestStockAlerts, Wall Street Corner, Penny Stock General, PennyStockInformer, Cannabis Financial Network News, BUYINS.NET, Fast Money Alerts, Penny Stock Beats, The Stock Psycho, Stock Shock and Awe, OTC Journal, Penny Stock Laboratory, Stock Market Media Group, InvestorPlace, Goldman Small Cap Research, Damn Good Penny Picks, Penny Picks, and Darth Trader reported earlier on PharmaCyte Biotech, Inc. (PMCB), and today choose to report on the Company, here at the QualityStocks Daily Newsletter.

PharmaCyte Biotech, Inc. concentrates on developing targeted treatments for cancer and diabetes applying its signature live cell encapsulation technology, Cell-in-a-Box®. This unique and patented technology is being used as a platform upon which treatments for many kinds of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. A clinical stage biotechnology Company and OTCQB-listed, PharmaCyte Biotech has its corporate office in Silver Spring, Maryland.

The Company is also working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other kinds of solid cancerous tumors.  PharmaCyte's treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or "cancer-killing" form. 

The capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. The live-cell encapsulation technology that the Company employs is a way to enclose living cells in protective "cocoons" around the size of the head of a pin. It encapsulates living cells, not drugs. PharmaCyte Biotech is advancing its new treatment for pancreatic cancer into the clinic in the United States, with study sites in Australia and Europe.

Furthermore, the Company is developing treatments for cancer built upon chemical constituents of the cannabis  plant, called cannabinoids. PharmaCyte is studying ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects typically associated with cancer treatments.

In January, PharmaCyte Biotech announced that its partner, Austrianova, successfully encapsulated the live cells used in PharmaCyte's therapy for its planned clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC). The cells are currently growing and dividing inside the Cell-in-a-Box® capsules.

PharmaCyte Biotech's Chief Executive Officer, Mr. Kenneth L. Waggoner, said, "We are now in the process of monitoring the growth and division of the live cells as they spend more time in a 'nutrient bath.' This will allow the cells to continue to grow and divide and then completely fill the capsules. Once the capsules are completely full of live cells, they will be placed into syringes and frozen. Austrianova will then commence testing the capsules in the frozen syringes to finalize PharmaCyte's clinical trial material."

PharmaCyte Biotech, Inc. (PMCB), closed Wednesday's trading session at $0.0468, up 2.86%, on 1,166,836 volume with 59 trades. The average volume for the last 3 months is 1,949,491 and the stock's 52-week low/high is $0.036/$0.105.

chart

Processa Pharmaceuticals, Inc. (PCSA)

NetworkNewsWire, Infront Analytics, Financial Content, Stockhouse, Barchart, Dividend Investor, Stockflare, MarketWatch, Biz Journals, Marketbeat, TradingView, PR Newswire, Stockopedia, Morningstar, YCharts, InvestorsHub, Simply Wall St, last10k, Biospace, and 4-Traders reported previously on Processa Pharmaceuticals, Inc. (PCSA), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Processa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company based in Hanover, Maryland. It is developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions. In October of 2017, the Company acquired the assets of Promet Therapeutics, LLC. It assembled a proven regulatory science development team, management team, as well as Board of Directors. Processa Pharmaceuticals lists on the OTC Markets Group's OTCQB.

The Processa Pharmaceuticals Team are experts in developing drug products from IND enabling studies to NDA submission. The Company's plan is to have a pipeline of drugs that already have some proof-of-concept clinical data supporting its clinical use in the indication selected and in 2-4 years following acquisition will either have completed the pivotal study or be ready for a pivotal study and out-licensing.

Processa's lead product is PCS-499. It will be investigated for the treatment of Necrobiosis Lipoidica, a necrotizing skin condition, caused by several pathophysiological changes. PCS-499 represents the first Processa Pharmaceuticals drug that can potentially be used in a number of unmet medical need conditions.

A second unmet medical need under investigation is the use of PCS-499 to treat radiation-related adverse effects in head & neck cancer. For both indications there is no Food and Drug Administration (FDA) approved treatments. In addition, the present standard of care is not adequate for patients.

Processa Pharmaceuticals announced in 2018 that the FDA granted the Company clearance to proceed with a Phase 2 clinical trial of PCS-499 in patients with Necrobiosis Lipoidica (NL) under an earlier submitted Investigational New Drug (IND) application. NL is a chronic, disfiguring condition affecting the skin and the tissue under the skin typically on the lower extremities with no currently approved FDA treatments. PCS-499 may provide a solution since PCS-499 and its metabolites affect numerous biological pathways, several of which contribute to the pathophysiology associated with NL.

In January, Processa Pharmaceuticals announced that the American Academy of Dermatology (AAD) selected the Processa presentation on the "Study Design and Preliminary Safety and Tolerability of PCS499 for Treatment of Necrobiosis Lipoidica (NL)" for an oral presentation and ePoster at the 2019 Annual Meeting of Washington, DC, March 1-5, 2019. Dr. Maya Das, VP of Clinical Research at Processa Pharmaceuticals will deliver the presentation.

Recently, Processa Pharmaceuticals announced the dosing of the first patient in the Phase 2 Necrobiosis Lipoidica (NL) clinical trial for PCS-499, taking place at 2 sites - University of Pennsylvania and University of Pittsburgh Medical Center (UPMC). The principal goal of the trial is to evaluate the safety and tolerability of PCS-499 in patients with NL. Nonetheless, the expectation is that the safety and efficacy data collected from the study will provide information for the design of future larger clinical trials.

Processa Pharmaceuticals, Inc. (PCSA), closed Wednesday's trading session at $2.50, up 11.11%, on 100 volume with 1 trade. The average volume for the last 3 months is 525 and the stock's 52-week low/high is $1.50/$4.78.

chart

The QualityStocks Company Corner

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Canaccord Genuity ("CG") recently issued a 'Speculative Buy' rating and price target of C$8 on shares of Plus Products (CSE: PLUS) (OTCQB: PLPRF). To view the full article, visit: http://nnw.fm/5kbwI.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.84, up 2.40%, on 212,355 volume with 462 trades. The average volume for the last 3 months is 81,544 and the stock's 52-week low/high is $2.81/$6.01.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday announced that its website, TGOD.ca, was recognized with two prestigious global awards. To view the full press release, visit: http://nnw.fm/IW9Nc.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.29, up 6.82%, on 772,445 volume with 1,201 trades. The average volume for the last 3 months is 1,435,438 and the stock's 52-week low/high is $1.61/$7.894.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted today in a publication from Investorideas.com, examining how, as the hemp and cannabis sectors mature, companies are racing to snap up industry leaders to enhance their position in the marketplace.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.536, up 4.63%, on 438,375 volume with 546 trades. The average volume for the last 3 months is 668,027 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings Inc. (OTCQB: NGTF), owner of Nightfood ice cream, secured distribution in 15 states and recorded greater than $150,000 in revenue in Q1 2019, the three months ended March 31, 2019. The majority of the reported revenue came from wholesale sales of the ice cream. NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company's newsroom at http://nnw.fm/NGTF. Also today, NetworkNewsWire released a report on the company detailing how NGTF recently received notice from the US Trademark Office that all requirements have been satisfied for registration of the Nightfood mark for ice cream in the United States.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.70, up 4.59%, on 325,084 volume with 119 trades. The average volume for the last 3 months is 551,708 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF), a leading provider of premium cannabis products and services for the medical and adult-use markets, today announced the Company expects to issue fiscal fourth quarter and full year 2018 financial and operating results before the markets open on April 30, 2019.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.6827, up 0.40%, on 117,580 volume with 73 trades. The average volume for the last 3 months is 320,922 and the stock's 52-week low/high is $0.413/$1.53.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) was featured today in the 420 with CNW by CannabisNewsWire. Lou Leon Guerrero, the Governor of Guam, has signed into law a bill that legalizes recreational cannabis in the U.S. territory. This signing comes after months of intense debate in this small Pacific island of 164,000 residents.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.6402, up 1.62%, on 608,829 volume with 292 trades. The average volume for the last 3 months is 508,846 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

Florida-based VPR Brands, LP (VPRB), an innovative technology holding company whose assets include patented atomization-related products and technology, today announces it has selected the corporate communications expertise of NetworkNewsWire ("NNW").VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed the day's trading session at $0.077, up 10.51%, on 89,030 volume with 13 trades. The average volume for the last 3 months is 68,354 and the stock's 52-week low/high is $0.026/$0.139.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. Lou Leon Guerrero, the Governor of Guam, has signed into law a bill that legalizes recreational cannabis in the U.S. territory. This signing comes after months of intense debate in this small Pacific island of 164,000 residents.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.0461, off by 0.86%, on 1,020,321 volume with 77 trades. The average volume for the last 3 months is 1,291,212 and the stock's 52-week low/high is $0.0425/$0.2099.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group Inc. (OTCQB: TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.Trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry. NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company's newsroom at http://nnw.fm/TRXD.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.54, even for the day. The average volume for the last 3 months is 2,053 and the stock's 52-week low/high is $0.23/$1.00.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") announces that it anticipates the closing of escrow for the acquisition of the 196,000 square foot facility in California will be on or about Monday, April 15th. The Company will provide an update upon completion of the acquisition. For further information, please visit the Company's website at www.transcanna.com.

TransCanna Holdings Inc. (CSE: TCAN) through its subsidiaries specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. TransCanna offers or will be offering services to support almost every aspect of the cannabis-related eco-system; from branding and design, to transportation and distribution, to marketing and sales.

California’s legalized adult-use recreational marijuana market opened for business January 1, 2018. The state’s Bureau of Cannabis Control is responsible for regulating all commercial activities in the state including cultivation, distribution and transportation. Moving cannabis products in the California marketplace is extremely challenging due to municipal and state laws and regulations, which can differ among cities and counties. Since cannabis remains illegal under federal law, Department of Transportation regulated companies are barred from participating in the market, which means companies looking to excel in the sector must hold a state-issued distributor license from the Bureau of Cannabis Control.

TransCanna has already entered into an Intellectual Property Rights and Royalty Agreement for the Track & Trace software platform required by the state of California. TCM Distribution, the operating company managed by TransCanna, has received a transportation and distribution permit from the city of Adelanto and a temporary transportation and distribution permit from the state of California. TransCanna has also executed a land lease to build a 10,000-square-foot transportation and distribution facility in Adelanto.

TransCanna is strategically creating a distribution network throughout California that places its facilities no further than a three-hour drive from most any client. The company is in the process of leasing or purchasing properly licensed and permitted warehouses strategically located throughout California along with new secure trucks, sprinter vans and/or armored vehicles.

TransCanna plans to create its own portfolio of branded products for the cannabis and hemp sectors. The company’s management team intends to translate the skills, knowledge and experience gained from a combined 60 years of branding and marketing experience in the music, professional sports and alcohol industries into TransCanna and the cannabis industry.

As part of the “TransCanna Way,” the company intends to manage most aspects of the supply chain from upper end procurement, branding, transportation and distribution, to marketing and sales.

Leading TransCanna as its CEO and chairman is James Pakulis, who has three decades of experience working with public and private entrepreneurial companies in a variety of emerging and high-growth sectors. He is formerly the president and a director of Lifestyle Delivery Systems Inc. (CSE: LDS) (OTCQB: LDSYF), a vertically integrated cannabis-related entity operating in California. Pakulis was chairman and CEO of General Cannabis Inc. which from 2010 to 2012 owned WeedMaps. Pakulis oversaw the company’s growth from zero to over $16 million in annual revenue in less than 24 months.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

For additional information, call: (604) 609-6199

TransCanna Holdings Inc. (CSE: TCAN), closed the day's trading session at $5.58, off by 2.96%, on 202,989 volume with 238 trades. The stock's 52-week low/high is $0.769/$5.75.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication titled, "Increasing Growth, Acceptance Move CBD Market Toward Mainstream," please visit: http://cnw.fm/2wC6P.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.65328, off by 5.18%, on 96,496 volume with 49 trades. The average volume for the last 3 months is 15,204 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Premium functional food and beverage company Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) this morning announced its partnership with San-Diego, California-based innovative beverage distributor Scout Distribution. To view the full press release, visit: http://nnw.fm/Ly7xu.

Headquartered in Vancouver, Canada, with operations in San Diego, Calif., Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)  is a premium food and beverage company that focuses on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses active hemp into a variety of premium foods, beverages and supplements and is poised for global distribution. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s mission is to become a leader in whole plant solutions by providing holistic remedies for a more natural alternative to pharmaceuticals and by guiding people toward a healthy lifestyle. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages and a focus on holistic health and wellness.

Publicly traded on the Canadian Securities Exchange (CSE: VIDA) and the OTCQX Best Market in the U.S. (OTC: PHVAF), the company’s strong balance sheet carries CAD$13 million with no debt or loans with ~60 million shares outstanding, and the company is now well-capitalized to fund major mainstream distribution with a solid structure that is poised for long-term growth.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who, as Phivida’s chief commercial officer, is tasked with driving new sales revenue growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

The whole plant hemp extract is infused into functional beverages, food and supplements to target a range of health and wellness conditions. Phivida strives to lead the industry in product quality through high-quality ingredients and best-in-class testing. The Company has partnered with Flora Labs to test and ensure consistency and potency of all products. Flora Labs is a world-class testing lab with stringent QA and QC quality assessment protocols and will provide Phivida with ongoing impartial quality testing.

Regulations

Federally legal under the 2014 Farm Bill, CBD from hemp oil is a rapid growth market across the U.S. When derived from marijuana, CBD remains a schedule 1 controlled substance, giving hemp-derived CBD oil-infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the U.S. Industrial Hemp laws to an agricultural commodity status and effectively removing hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the U.S. CBD-hemp sector. In February 2018, the Supreme Court presided over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp and the legality of industrial hemp. In the final ruling, the Supreme Court unequivocally determined that hemp (and its derivatives), when produced domestically under the Farm Bill, are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA), giving the Farm Bill primary jurisdiction over the governance of the CBD-hemp oil industry in the U.S.

The DEA further conceded it does not “seek to control cannabinoids” and that only marijuana-derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g., U.S. Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreational cannabis, with edibles to be added in 2019. The bill officially became law as of Oct. 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

Phivida Brands

  • Vida+: Vida+ is the company’s premium, clinical-grade-strength, full-spectrum hemp oil extract and capsule line designed to help people feel their best. The products are sourced from the best organic hemp and natural ingredients on the market and are third-party lab tested for quality, purity and potency at world-class facilities.
  • Oki: The Oki lifestyle brand is the company’s newly launched line of functional beverages and supplements infused with active hemp extract and will be available to consumers in up to 2,400 natural specialty store locations within the United States. Oki beverages are infused with 10 milligrams of active hemp extract per bottle and come in two different formulations: iced teas and flavor-infused water, each available in four different 16-ounce flavors. Oki supplements are available in tinctures or capsules that range in doses from 600-1,800 total milligrams of active hemp extract.
  • All products contain non-GMO, natural and organic ingredients and are plant-based and vegan friendly and packaged in sleek, 100 percent recyclable glass containers.

WeedMD-Phivida Joint Venture

Phivida has partnered with WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on manufacturing, marketing and distributing cannabinoid-infused beverages. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distributing cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets. WeedMD will be the exclusive cannabis supplier and distributor for CanBev cannabis-infused beverages. Phivida will be responsible for product innovation, research and development, formulation and branding.

Strategic Agreements

Phivida has an exclusive national agreement with Natural Specialty Sales (“NSS”), an Acosta company. NSS is recognized as the industry leader in natural/specialty retail channel trade across the U.S. Phivida’s launched OKI brand of premium CBD products is now the exclusive CBD-infused beverage and health supplements products brand represented by NSS. This establishes Phivida as the first CBD brand company to officially cross over into national mainstream distribution across the U.S., providing new access to over 2,400 retail locations in a major distribution channel market valued at over USD $4.1 billion in retail sales.

The NSS exclusive agreement provides access to a national network of retail stores across the U.S. This national network includes major retail banners such as: Whole Foods Market, Sprouts Farmers Market, National Coop Grocers, etc. The partnership also provides the opportunity to access an additional 25,000 national conventional grocery supermarkets, including Walmart, Target, Kroger, Publix and others, via Acosta’s national sales network.

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.634375, off by 4.90%, on 203,106 volume with 118 trades. The average volume for the last 3 months is 98,549 and the stock's 52-week low/high is $0.05/$1.06.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, is preparing for a future surge in the CBD market, projected to potentially reach $16 billion by the year 2025 (http://nnw.fm/1jTxN). To view the full article, visit: http://nnw.fm/wxM75. Also today, NetworkNewsWire released a report on the company detailing how ETST is securing a commanding position in the burgeoning cannabis sector through its innovative approach and overall compliance with the 2018 Farm Bill.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.62786, off by 3.41%, on 10,166 volume with 15 trades. The average volume for the last 3 months is 31,322 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), in another move to signal its international growth strategy, has changed its ticker symbol on the OTCQB Venture Market from 'SHRV' to 'SHRG'. The move follows a corporate name change to Sharing Services Global Corporation. The company also says that it will pursue opportunities abroad (http://nnw.fm/S9Nue).

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed the day's trading session at $0.28, off by 6.64%, on 2,200 volume with 5 trades. The average volume for the last 3 months is 12,489 and the stock's 52-week low/high is $0.17/$0.45.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.